China Health Group Inc.

As of June 30, 2024, China Health Group Inc. carries a market capitalization of 99.54M, placing it among publicly traded companies globally. Its enterprise value stands at 89.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, China Health Group Inc. has 995.35M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, China Health Group Inc. maintains a current ratio of 3.23, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, China Health Group Inc. recorded an income tax benefit of -168,695.01 rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, China Health Group Inc.'s stock has declined approximately 58.68% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.15.

These figures are as of June 30, 2024. Total book value stands at 99.04M, with working capital of 89.19M providing operational flexibility.

China Health Group Inc.'s most recent stock split took place on October 13, 2014 with a 500:747 split ratio.